Glimiprex MF 1/500 Tablet PR
By Glimiprex MF
Rx
15 Tablet PR in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg)

Manufacturer - Aristo Pharmaceuticals Pvt Ltd
Mercantile Chamber, 3rd Floor, 12, J.N. Heredia Marg, Ballard Estate, Mumbai – 400 001, India.

Expires on or after
January, 2026

liver
When it comes to the use of Glimiprex MF 1/500 Tablet PR, caution is advised for individuals with liver disease. It may be necessary to adjust the dosage of Glimiprex MF 1/500 Tablet PR in such cases, so it is crucial to consult with your doctor before starting the medication. Typically, Glimiprex MF 1/500 Tablet PR is initiated at a low dose for patients with mild to moderate liver disease. However, it is not recommended for use in individuals with severe liver disease. It is important to follow your healthcare provider's guidance closely to ensure safe and effective use of this medication.

kidney
Glimiprex MF 1/500 Tablet PR should be used carefully in patients with kidney disease. Dose adjustment may be necessary. Avoid in severe kidney disease. Regular kidney function tests are recommended during treatment. Consult your doctor for guidance.

alcohol
It is not safe to mix alcohol with Glimiprex MF 1/500 Tablet PR.

driving
If you experience symptoms of low or high blood sugar, avoid driving while taking Glimiprex MF 1/500 Tablet PR to ensure safety.

pregnancy
Glimiprex MF 1/500 Tablet PR may be unsafe during pregnancy. Limited human studies suggest risks to the developing baby. Consult your doctor for a careful assessment of benefits and risks before using this medication.

breastfeeding
Caution Glimiprex MF 1/500 Tablet PR is not safe to use while breastfeeding as it may cause toxicity to the baby.
Habit Forming | No |
Chemical Class | Biguanide |
Therapeutic Class | ANTI DIABETIC |
Action Class | Sulfonylureas (Insulin Secretogogues) |
₹109.5
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024